Lauren Cook, DO
Family Medicine · Levittown, PANPI 1770844185
Payments from drug & device makers
Across 905 payments — averaging $14.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novo Nordisk$2K
- Pfizer$1K
- Lilly USA, LLC$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$831
- AstraZeneca$638
- plus $5K from 53 others
What the payments were for
- Food & beverage$13,166100%
- Education$610%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Skyrizi$122
How this compares
$13,227 in reported general payments places this provider in the 95th percentile of 4,967 family medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 93 | $89,758 |
| JanuviaSitagliptin Phosphate | 76 | $74,939 |
| EliquisApixaban | 75 | $69,631 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 76 | $47,816 |
| TrulicityDulaglutide | 46 | $43,567 |
| FarxigaDapagliflozin Propanediol | 53 | $39,409 |
| MounjaroTirzepatide | 38 | $39,183 |
| JardianceEmpagliflozin | 34 | $36,059 |
| XareltoRivaroxaban | 36 | $29,268 |
| RexultiBrexpiprazole | 19 | $28,945 |
| UbrelvyUbrogepant | 21 | $24,063 |
| Nurtec OdtRimegepant Sulfate | 14 | $23,099 |
| MyrbetriqMirabegron | 41 | $21,648 |
| Breo ElliptaFluticasone/Vilanterol | 54 | $20,791 |
| JanumetSitagliptin Phos/Metformin Hcl | 24 | $20,742 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Nurtec Odt, Premarin | $1,423 | $102,280112 claims |
| MerckJanuvia, Janumet, Belsomra | $204 | $101,537114 claims |
| Novo NordiskOzempic | $1,928 | $89,75893 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $1,280 | $82,74984 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $409 | $68,607130 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $638 | $47,81966 claims |
| AbbVieUbrelvy, Vraylar, Linzess | $2,250 | $47,77646 claims |
| Boehringer IngelheimJardiance | $281 | $36,05934 claims |
| Johnson & JohnsonXarelto | $107 | $29,26836 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $157 | $28,94519 claims |
| Astellas Pharma US IncMyrbetriq | $248 | $21,64841 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $831 | $6,68613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Levittown
- Kenneth FoxLevittown$865K
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
- Bryce PalchickPittsburgh$4.7M
- Harris CohenHorsham$3.7M
- Shari RozenPittsburgh$2.9M
- Richard CookUniontown$2.1M
- Bruce GebhardtErie$2.1M
- Peter CognettiScranton$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.